Literature DB >> 17296301

QSAR analysis for heterocyclic antifungals.

Pablo R Duchowicz1, Martín G Vitale, Eduardo A Castro, Michael Fernández, Julio Caballero.   

Abstract

We perform linear regression analyses on 1202 numerical descriptors that encode the various aspects of the topological, geometrical and electronic molecular structure with the aim of achieving the best QSAR relationship between the antifungal potencies against the Candida albicans strain and the structure of 96 heterocyclic ring derivatives. As a realistic application we employ the model found to predict the biological activity for 60 non-yet measured compounds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296301     DOI: 10.1016/j.bmc.2007.01.039

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

Review 1.  Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines (GA-SVM).

Authors:  Michael Fernandez; Julio Caballero; Leyden Fernandez; Akinori Sarai
Journal:  Mol Divers       Date:  2010-03-20       Impact factor: 2.943

2.  QSAR of heterocyclic antifungal agents by flip regression.

Authors:  Omar Deeb; Brian W Clare
Journal:  J Comput Aided Mol Des       Date:  2008-06-24       Impact factor: 3.686

3.  Models for the prediction of receptor tyrosine kinase inhibitory activity of substituted 3-aminoindazole analogues.

Authors:  Monika Gupta; Harish Dureja; Anil Kumar Madan
Journal:  Sci Pharm       Date:  2011-04-28

4.  Predictive Quantitative Structure-Activity Relationship Modeling of the Antifungal and Antibiotic Properties of Triazolothiadiazine Compounds.

Authors:  Michael Appell; David L Compton; Kervin O Evans
Journal:  Methods Protoc       Date:  2020-12-27

5.  1,2,4-Oxadiazole-Based Bio-Isosteres of Benzamides: Synthesis, Biological Activity and Toxicity to Zebrafish Embryo.

Authors:  Sen Yang; Chao-Li Ren; Tian-Yang Ma; Wen-Qian Zou; Li Dai; Xiao-Yu Tian; Xing-Hai Liu; Cheng-Xia Tan
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.